From risk perception to action: A qualitative study of self-management in hematopoietic stem cell transplant patients

Abstract

A descriptive qualitative study was conducted to explore risk perception, self-management challenges, and coping strategies among Chinese hematopoietic stem cell transplantation (HSCT) patients, using the Health Action Process Approach (HAPA) as the guiding framework. Purposive sampling, based on the principle of information power, was employed to recruit 20 HSCT patients from a hospital in south-central China between May and August 2024. The HAPA model informed the development of semi-structured interview questions, and the data were analyzed using a combination of thematic analysis and framework analysis. The findings indicate that both risk perception and self-efficacy play a critical role in motivating patient engagement in self-management. Main barriers to self-management included difficulties in symptom control, lifestyle modification, psychological adjustment, and healthcare-related financial burdens. Effective coping strategies reported by participants involved the use of digital tools, seeking professional medical advice, maintaining self-management journals, and drawing on family and social support networks. In clinical practice, healthcare professionals may capitalize on the heightened risk perception and self-efficacy during the peri-transplant period to promote the transition from risk perception to actionable self-management behaviors. In contrast, during the early post-discharge phase, when both risk perception and self-efficacy tend to decline, tailored support systems and resource allocation are helpful for maintaining the transition from risk perception to self-management action.

Graphical Abstract

Keywords

hematopoietic stem cell transplantation (HSCT)Health Action Process Approach framework (HAPA)self-management qualitative study

Introduction

Hematopoietic stem cell transplantation (HSCT) is well-established treatment for malignant hematological diseases, aplastic anemia, genetic blood disorders, and other conditions¹. In China, 39,918 HSCT procedures were reported over the past 2 years². Among patients with malignant hematological diseases undergoing matched sibling donor allogeneic HSCT (MSD allo-HSCT), the 1-year overall survival rate is 74.1%³, with a 3-year survival rate for grade II–IV graft-versus-host disease (GVHD) of approximately 45%⁴. Despite these outcomes, HSCT entails a prolonged recovery period characterized by significant challenges, including immunosuppression, increased infection risk, adverse reactions to immunosuppressive drugs, disease relapse, and transplant-related complications^5–7. These factors impair patients’ quality of life, complicate prognosis, increase healthcare costs, and pose life-threatening risks⁸.

The success of HSCT depends on a multifaceted effort that includes advances in medical technology, high-quality supportive care, and active patient self-management. Self-management refers to the day-to-day activities and decisions patients use to manage chronic conditions⁹. In this study, self-management encompasses managing symptoms, adhering to complex treatment regimens, addressing both physiological and psychosocial consequences of the disease, monitoring changes in health status, and communicating effectively with healthcare providers. Effective post-HSCT self-management is a major determinant of outcomes, including control of GVHD, prevention of infection, medication adherence, and quality of life.

HSCT patients often experience prolonged recovery periods and face complex self-management tasks. Approximately 60%–90% of allogeneic HSCT patients develop long-term complications, such as GVHD, infections, neurocognitive deficits, and hypogonadism. These complications necessitate ongoing follow-up to monitor for recurrence and prevent further progression^10,11. Effective self-management involves the use of self-regulation strategies, including goal setting, self-monitoring, and problem-solving, to manage both the disease and its associated risk factors¹². However, patients frequently encounter barriers such as inadequate medical information, psychological distress, financial constraints, and geographic disparities in healthcare access, all of which complicate effective self-management^13–15.

Current research on post-discharge self-management among HSCT patients has largely relied on quantitative designs and focused primarily on biomedical interventions. These approaches have yielded valuable estimates of symptom prevalence and self-reported behaviors but provide limited insight into the subjective experiences, contextual influences, and dynamic decision-making that underlie self-management^16,17. This gap underscores the need for qualitative inquiry to elucidate how such behaviors are perceived, adopted, and sustained.

Risk perception, defined as an individual’s subjective judgment of disease susceptibility, is an important predictor of health behaviors and self-management¹⁸. Among people with type 2 diabetes, Li et al.¹⁹ discovered that higher perceived risk was associated with greater self-management, suggesting that risk perception may precede behavior change. In a UK-based study, reflective-deliberative risk perception negatively predicted intention, whereas affective-experiential risk perception positively predicted intention²⁰. This heterogeneity underscores the need to examine how different forms of perceived risk are constructed and enacted in everyday self-management.

According to the Health Action Process Approach (HAPA) model, risk perception is a core factor in initiating behavior change during the intention-to-change stage. In the context HSCT, the persistent risks of disease recurrence and GVHD highlight the need for a deep understanding of how risk perception influences self-management behaviors, such as dietary control, medication adherence, and symptom monitoring. However, there is a lack of in-depth exploration of how risk perception drives these behaviors, especially considering the influence of psychobehavioral stages and cultural contexts. Using qualitative methods²¹, this study aims to apply the HAPA framework to examine the self-management process among Chinese HSCT patients, from the intention to take action, through action, and into maintenance^22,23. By integrating patients lived experiences with a theoretical framework, this study will provide a comprehensive understanding of how risk perception, motivation, and coping strategies influence self-management behaviors.

Methods

Design

The study employed a qualitative descriptive design and conducted semi-structured interviews with post-HSCT patients. The thematic analysis^24,25 was used to analyze the interview data. Descriptive qualitative research, rooted in the philosophy of naturalistic inquiry, aims to produce straightforward descriptions of phenomena as they occur in their natural state, minimizing interpretive inference²⁶.

The interviews were conducted by H.Y., a specialist nurse in stem cell transplantation with a postgraduate degree and substantial experience in qualitative research and interviewing techniques. Her in-depth understanding of the treatment and recovery processes of the study participants contributed to the reliability and richness of the data collected. Conducted from May to August 2024, this study received approval from the Institutional Ethics Committee of the Second Xiangya Hospital of Central South University (No.2024-0275). In addition, the study adhered to the Consolidated Criteria for Reporting Qualitative Studies (COREQ) checklist²⁷.

Sampling and participants

The participants were selected using a purposive sampling approach combined with maximum variation in terms of age, gender, financial status, self-health status, disease type, HSCT types, and duration after HSCT. Post-HSCT patients, treated and reviewed at a tertiary teaching hospital in Hunan Province, were recruited by the nurse in charge of a specialized outpatient clinic. The researcher (H.Y.) approached eligible patients, obtained informed consent, conducted all interviews, and oversaw standardized data collection. Sample size was guided by the information power framework, considering the study’s narrow aim, high sample specificity, strong interview dialogue, and a case-focused analytic strategy²⁸.

Inclusion criteria were (1) post-HSCT patients who had been discharged and had at least 2 months of independent home-based self-management, (2) at least 18 years old, (3) ability to understand and speak Chinese, and (4) willingness to discuss their experiences with HSCT self-management. Exclusion criteria were (1) current psychiatric disease, (2) cognitive impairment, and (3) language barriers.

Data collection

Between May and August 2024, we screened 35 patients from the HSCT outpatient clinic of the Hematology Department by using electronic medical records. Of these, 22 met all inclusion criteria. Exclusions included 8 patients with ineligible transplant types, 3 who refused participation, 2 with language barriers. Of the 22 eligible participants, 20 completed interviews (1 declined due to discomfort, and 1 withdrew due to scheduling conflicts). Data collection was stopped once information saturation was reached, which was confirmed through repeated coding: no new themes emerged in the last three consecutive interviews. The final sample size (n = 20) is consistent with the principles of purposive sampling and information saturation in qualitative research.

Included patients had three types of hematological malignancies: acute leukemia, lymphoma, and myelodysplastic syndrome. All participants underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT), which was classified into three subtypes based on HLA matching: haploidentical HSCT, HLA-identical HSCT, and 10/10 matched unrelated donor (MUD) HSCT. Patients’ self-reported health status was categorized into three levels: (1) Good: no physical discomfort, normal daily activities, and no need for regular medical intervention; (2) Moderate: mild occasional discomfort with minimal impact on daily activities; (3) Poor: persistent or significant discomfort impairing daily activities and potentially requiring regular medical care. Financial status was assessed based on monthly family income (RMB), with three categories: <5000, 5000–10,000, and >10,000.

Data were collected through face-to-face semi-structured interviews conducted in Chinese. Before each interview, we explained the study aims, procedures, and interview topics to participants and established rapport. All participants provided written informed consent, including consent for audio recording and note-taking. Interviews were conducted one-on-one in a private office, with only the participant and the interviewer (H.Y.) present.

Each participant was interviewed for 20–40 min. During the interviews, participants described their experiences and needs regarding post-discharge self-management. The interview guide was developed on the basis of the HAPA framework and a review of literature. Following two pilot interviews with post-HSCT patients, the guide was refined and finalized (see Table 1).

Table 1.

Semi-structured interview guide.

HAPA framework	Constructs	Interview questions
Motivational Phase	Risk perception: The perception of health-threatening factors.	1. How have your life changed since undergoing HSCT? Are you aware of potential health risks and complications post-HSCT? What do you know about them?
	Outcome Expectancies: Cognitive appraisals of outcome expectancies for specific behavior.	2. When you keep up with these health habits, what do you think will happen, both the positives you hope for and any drawbacks?
	Action self-efficacy: Belief in one’s own capability to initiate and perform a behavior.	3. What are your thoughts on post-discharge self-management? How confident are you in correctly following your doctor’s instructions?
Volitional Phase	Action planning: Specific plans formulated to attain health behavior goals.	4. Have you made plans and set goals for your self-management post-HSCT? What aspects do these plans include?
	Coping planning: Predefined plans for overcoming anticipated barriers during behavioral implementation.	5. What specific strategies in self-management practices have you implemented? Please provide examples, such as medication care and dietary management?
		6. What challenges have you encountered in self-management post-HSCT? How did you cope with these challenges? Please provide examples.
	Maintenance self-efficacy: The confidence in sustaining behaviors over the long term and overcoming challenges.	7. When you plan and act on your self-management, how confident do you feel that you can keep doing this, even when it’s hard? What gives you that confidence, or makes it harder to feel confident?
	Recovery self-efficacy: The confidence in recovering from behavioral failures or disruptions and restarting.	8. Have you ever struggled to stick to your self-management plan? In such cases, did you feel confident in restarting? What factors helped you get back on track and keep going? 9. What tools, methods, and resources have you used in self-management post-HSCT? Please share examples. 10. What additional help or resources would you like in self-management post-HSCT?

The interviews began with an open-ended question about patients’ perceptions and feelings about their condition after HSCT. The researcher recorded the interviews both audibly and through note-taking. By observing the interviewees’ non-verbal cues, the researcher followed up with appropriate questions while avoiding leading questions. Before concluding, participants were invited to add or clarify any additional information. The interviews were transcribed verbatim within 24 h, and participants were assigned codes (e.g. P1 = Participant 1) to ensure anonymity. The transcripts were uploaded to NVivo12 (QSR International) for qualitative analysis.

Data analysis

Thematic analysis²⁹ and HAPA framework analysis³⁰ were applied to identify emerging themes and assign them to pre-selected theoretically driven domains, thus facilitating the identification of psychological and behavioral changes in the self-management process.

Step 1: Familiarization. Two researchers, Z.X. and H.Y., extracted the audio data from the recording device and transcribed it into text. They then proofread, summarized, and organized the data into interview transcripts. Step 2: Generating Codes. The interview transcripts were thoroughly read, and key words, phrases, or sentences were identified and assigned preliminary codes. Step 3: Constructing Themes. Preliminary codes were compared and grouped based on similarity, and major categories were created using a thematic map. These themes were then mapped deductively to the HAPA framework. Step 4: Revising Themes. Themes were reviewed against the dataset, with similar or related themes grouped together for revision. Step 5: Defining Themes. The naming and descriptions of the themes clarified their content and scope. Step 6: Producing the Report. A report was written based on the identified themes, incorporating relevant literature to explain and justify them. Anonymized quotes were used to illustrate the core meaning of the themes.

Three researchers (X.L., H.Y., and X.Y.) independently coded the data. H.Y. and X.Y. both nursing professors with extensive experience in nursing management and hematology care, work at a hospital and a university, respectively. This collaborative approach ensured that the final report would be comprehensive and credible.

Results

Participant characteristics

This study employed the HAPA framework to conduct semi-structured interviews with 20 post-HSCT patients. Participants’ ages ranged from 18 to 61 years, with a mean age of 37.8 years. Among these 20 participants, 16 were diagnosed with acute leukemia, 2 with lymphoma, and 2 with myelodysplastic syndromes. Time post-HSCT ranged from 3 to 41 months, with a mean of 16.6 months. Detailed characteristics of the study participants are presented in Table 2.

Table 2.

Characteristics of HSCT patients (n = 20).

Characteristics		n
Age, y	Median (range)	37.8 (18–61)
Sex	Male	11
Sex	Female	9
Marital status	Single	5
Marital status	Married	15
Education level	Primary or less	2
	Secondary	9
	Tertiary or higher	9
Occupation	Student	3
	Clerk/Worker	8
	Farmer	2
	Sole proprietor	7
Diagnosis	Acute leukemia	16
	Lymphoma	2
	Myelodysplastic syndrome	2
Allo HSCT type	Haploidentical	10
	HLA-identical	7
	10/10 MUD	3
Post-HSCT duration (mo)	3–6	3
	7–12	10
	13–18	2
	25–30	2
	37–42	3
Family income (RMB/mo)	<5000	3
	5000–10,000	10
	>10,000	7
Self-rated health	Good	13
	Moderate	3
	Poor	4

The analysis of the interview data revealed 7 themes and 12 subthemes across two phases: motivational phase (risk perception, outcome expectations, action self-efficacy) and volitional phase (action planning, coping strategies, maintenance self-efficacy, recovery self-efficacy).

The results showed that HSCT patients’ risk perception followed a phased pattern. During the peri-transplant period, patients exhibited heightened awareness of life-threatening risks, which coincided with increased action self-efficacy, thereby fostering strong adherence to medical instructions. However, as risk perception decreased upon discharge, self-management behaviors declined. When complications such as GVHD emerged, risk perception increased again, leading to the restoration and maintenance of self-management behaviors. Main barriers to self-management included difficulties in symptom control, lifestyle modification, psychological adjustment, and healthcare-related financial burdens. Effective coping strategies reported by participants involved the use of digital tools, seeking professional medical advice, maintaining self-management journals, and drawing on family and social support networks (see Graph 1, Table 3).

Graph 1.

HAPA-guided conceptual model of self-management for HSCT patients.

Table 3.

Summary of themes and sub-themes.

HAPA framework	Themes	Sub-themes
Motivational Phase	Risk perception	Cautious risk perception
		Insufficient risk perception
		Adaptive risk perception
	Outcome expectancies	Positive outcome expectancies
	Outcome expectancies	Negative outcome expectancies
	Action self-efficacy	High action self-efficacy
	Action self-efficacy	Low action self-efficacy
Volitional Phase	Action planning	Planned behavioral execution
	Coping planning	Barriers to action
	Coping planning	Strategies for action
	Maintenance self-efficacy	Maintenance self-efficacy
	Recovery self-efficacy	Recovery self-efficacy

Risk perception

The analysis of the interview data identified three primary types of risk perception among post-HSCT patients: cautious, insufficient, and adaptive. This typology was based on participants’ detailed accounts of their experiences.

Cautious risk perception

During the peri-transplant period (from hospital admission to pre-discharge), patients are exposed to several HSCT-specific high-risk factors, including ultra-high-dose chemotherapy preparation, transplant failure, and GVHD. As a result, their perceived risks were heightened. Patients subjectively assessed their disease susceptibility and severity as extremely high, leading to increased alertness, anxiety, and fear.

“The pre-transplant discussion was jarring. They said if the transplant failed, complications could even be fatal. I went into it with a gambler’s resolve—if it worked, it’d be a win.” (P9) “Once in the transplant isolation ward, I was stuck there all day, I began to feel vulnerable and had no choice but to follow the doctors’ and nurses’ orders.” (P3)

Insufficient risk perception

Some participants’ overdependence on clinicians and their prior experiences mpaired their ability to accurately perceive risks. “Since contracting this disease was uncontrollable, I left it to fate. Regardless of the risks, doctors would handle everything, so I just needed to follow their instructions” (P19).

Adaptive risk perception

Post-transplant risk perception followed a phased pattern, initially decreasing and then gradually increasing. “I was fully cooperative throughout the transplant process. However, after the transplant, I couldn’t resist meeting friends, causing flu-triggered GVHD. Now I’ll strictly follow medical rules” (P17).

Outcome expectancies

Outcome expectations refer to a patient’s evaluation of the potential outcomes and effects of specific behaviors.

Positive outcome expectancies

I held to one hope: if I strictly adhered to the doctors’ instructions—disinfecting, isolating, resisting cravings—I would regain a normal life. (P2)

Negative outcome expectancies

I anticipated constant vomiting from immunosuppressants, but mild nausea actually increased my confidence in taking them on time. (P7)

Action self-efficacy

Patients in the peri-transplant period demonstrated high action self-efficacy, driven by survival imperatives, though some expressed doubts about their ability to manage their health in the long term.

High action self-efficacy

“In the ward, one thought kept me going: my son was waiting for me, and I was determined to overcome the disease.” (P1) “Every morning, I would say, Welcome, stem cells, into my body. Let’s work together to complete the treatment.” (P20)

Low action self-efficacy

I’m not sure if I can stick to the diet long-term. It’s just too hard. (P18)

Action planning

Formulating specific action plans serves as a premise for translating health behavior goals into practice. However, some patients challenge due to inertia, forgetfulness, and competing demands. “I posted my medication schedule on the fridge and set three phone alarms. When they ring, I take the pills immediately. This method helped me avoid missing any doses for half a year” (P5).

Coping planning

Barriers to action

Although post-HSCT patients initiate self-management behaviors, they continue to face a series of barriers to action, which become more pronounced as the post-discharge period extends. (1) Managing disease- and transplant-related symptoms: a significant medication burden, persistent symptoms that interfere with daily life, and avoidance of invasive follow-up examinations. (2) Adapting to necessary lifestyle changes, including strict dietary restrictions, proves extremely difficult, with non-adherence potentially increasing the risk of severe GVHD. (3) Psychological adjustment: patients frequently experience anxiety about prognosis, concerns about body image, feelings of social isolation, and helplessness stemming from self-management failures. (4) Financial burden: although basic health insurance mitigates part of the financial strain, the financial burden of post-HSCT rehabilitation remains considerable.

These interconnected obstacles collectively impede patients’ self-management capacity.

Barriers to symptom management

“There are too many medications. Keeping track of them feels burdensome. Since the transplant, I have experienced persistent nausea and vomiting, making it difficult to eat without discomfort.” (P14) “After the transplant, I was most afraid of the bone marrow aspiration follow-up check. I put it off as long as possible, so I haven’t had this check-up in the past six months.” (P11)

Barriers to lifestyle modification

Post-transplant diets are stringent. One particular meal was so unappetizing that I indulged in two bites of a scallion pancake. I did not anticipate the subsequent gastrointestinal GVHD, which I now deeply regret. (P9)

Barriers to psychological adjustment

After the transplant, I stayed alone for an extended period, and it seemed that the care from others gradually diminished. I felt excluded by both friends and society, which was deeply distressing. (P10)

Barriers to financial burden

Since the transplantation, my family has exhausted our resources. (P15)

Strategies for action

The interviews indicate that information tools are frequently used to track key milestones and gather health information; however, concerns regarding the reliability of such information often induce anxiety. Patients place significant value on professional medical resources, particularly in medication guidance, symptom monitoring, and adjustments to treatment plans. They indicate that clear communication and peer support play a significant role in improving adherence and confidence. When facing emotional and daily life challenges, patients proactively seek family and social support. Furthermore, using daily life management tools, such as self-management diaries and dietary tracking apps, effectively reduces the risk of complications and strengthens confidence in daily self-management. These strategies facilitate a transition from an intention to engage in self-management to the sustained practice of “I can adhere.”

Use of information tools

“To monitor the number of days post-HSCT, I used a countdown application on my phone.” (P2) “I searched for dietary recommendations post-HSCT on platforms such as TikTok and Little Red Book.” (P5) “When looking up how to take a medication online, I noted conflicting information, which only confused me more.” (P12)

Support from professional medical resources

“A video consultation with healthcare professionals to discuss each medication in detail could improve adherence and ensure proper use.” (P12) “Patient education sessions are particularly helpful, as they introduce us to transplant-related knowledge. Last time, a fellow patient’s sharing made me realized that I need to keep up with self-management.” (P6)

Support from family and social resources

During a period of severe emotional distress, I contacted the psychological crisis hotline. (P16)

Use of tools for daily life management

“I record my daily meals, marking problematic foods in red to avoid eating them later, which has been helpful in preventing the recurrence of diarrhea.” (P3). “I use a video-sharing platform to record my routines. This practice improves my daily management.” (P13).

Maintenance self-efficacy

Maintenance self-efficacy was identified as one of the factors influencing their long-term adherence to care plans and ability to overcome challenges. Some participants expressed confidence in self-management of post-HSCT. “I am not used to receiving care from others; instead, I fear that it might increase the risk of infection. Making a daily checklist for myself and following it makes me feel more at ease” (P4).

Recovery self-efficacy

Patients reported actively adjusting their coping strategies in the face of health fluctuations and reestablished confidence to restart and maintain self-management behaviors.

I felt safe six months after discharge. But last month, sudden gum bleeding and weakness made me stop taking my temperature. My daughter urged me to the hospital, and that’s when I realized I couldn’t let my guard slip. After adjusting my meds, I’m now taking my temperature and tracking my diet more carefully—this illness needs careful care. (P8)

Discussion

This research employed the HAPA framework to explore the risk perception, self-management challenges, and coping strategies among HSCT patients. In line with the HAPA model, both risk perception and action self-efficacy were found to play pivotal roles in shaping behavioral intentions^31,32. The volitional phase revealed substantial barriers to action planning and coping implementation, particularly in the areas of symptom management and lifestyle modification. Sustaining self-management behaviors was further hindered by challenges related to symptom control, lifestyle adjustment, psychological adaptation, and financial burden.

Stage characteristics of risk perception and self-management behavior in HSCT patients

According to the HAPA model, health behavior change begins with a motivational phase, during which risk perception and action self-efficacy jointly contribute to the formation of behavioral intentions³³. In this study, post-discharge HSCT patients demonstrated a dynamic pattern of risk perception, characterized by an initial decline followed by a gradual increase over time.

During the perioperative period, patients exhibited both heightened risk perception and strong behavioral intentions. This phenomenon may be explained by their acute awareness of life-threatening health conditions, a strong desire to survive, and a high level of trust in medical care. These factors appeared to facilitate their transition into the volitional phase, during which they actively formulated specific action plans, such as strict adherence to treatment protocols and proactive engagement in acquiring self-management skills.

In the early post-discharge period, risk perception and self-management behaviors showed a noticeable decline. Patients frequently exhibited inconsistent or poorly structured self-management plans and behaviors. Notably, individuals facing financial hardship often delayed or avoided follow-up visits, despite recognizing their clinical significance. This phenomenon can be attributed to two factors. On one hand, patients transitioning from hospital to home may develop a false sense of security, believing that the most critical stage of recovery has passed. This optimism bias may result in overconfidence in their recovery trajectory and an underestimation of potential risks, such as GVHD. On the other hand, the shift from a highly structured hospital environment to the comparatively unmonitored home setting introduces multiple barriers to effective self-management. These include physical fatigue, insufficient health-related information, and financial strain³⁴. Such contextual challenges substantially impair patients’ capacity for daily self-care, leading to reduced adherence to recommended self-management practices. Similarly, Yu et al.³⁵ also reported a decline in self-management adherence during the early recovery phase following hospital discharge in HSCT patients.

When complications such as GVHD arise, patients’ risk perception typically increases, and self-management behaviors strengthen. Several studies have shown that the early post-discharge period following HSCT is often characterized by a high incidence of complications, including acute GVHD and infections^5,6,35. However, insufficient self-management during this phase may hinder patients’ ability to effectively monitor and respond to their condition. Participants reported that access to medical resources and family support enables more effective disease coping and self-management. This finding aligns with research on self-management in ischemic stroke patients, which suggests that individuals who overestimate the risk of recurrence tend to experience greater fear of disease progression and exhibit better health behaviors at 1-month post-discharge. In contrast, those who underestimate the risk often demonstrate poorer health behaviors³⁶. Furthermore, qualitative data reveal that although psychological distress can temporarily hinder self-management execution in GVHD patients, active coping strategies are key to facilitating recovery and maintaining long-term adherence to self-care practices³⁷. During recovery, HSCT patients report an increased risk perception compared with the lower levels observed immediately post-discharge. However, this heightened perception remains lower than during the peri-transplant period and stabilizes at a moderate level. This suggests that HSCT patients may enter an adaptive phase of “living with the disease.”

Self-management strategies for HSCT patients based on the HAPA model

Based on this study, self-management interventions for HSCT patients should leverage the heightened risk perception and self-efficacy observed during the peri-transplant period to support the shift from risk awareness to concrete health behaviors. To this end, healthcare professionals can implement patient-centered discharge education programs^38,39 that emphasize the message: “discharge does not equate to recovery.” Such programs should incorporate patient narratives, visual aids, and other educational tools to clearly communicate the risks of post-discharge complications, such as GVHD, and underscore the potentially serious consequences of dietary non-adherence⁴⁰.

Priority should be given to supporting patients with limited perception and poor self-management behaviors during the early stages post-discharge rehabilitation. Proactive follow-up care can facilitate continuous communication through transitional support mechanisms such as dedicated nurse hotlines, online consultation platforms, and peer support programs, thereby empowering patients in their self-management efforts⁴¹. Digital interventions should be promoted to help patients maintain self-management efficacy and behaviors⁴². Participants reported that digital goal-setting tools, including mobile applications for symptom monitoring, medication reminders, and features, in supporting daily self-management. However, dietary management remains a significant challenge, particularly due to negative sensory experiences and low acceptance of sterile dietary regimens. These difficulties often conflict with the widespread preference for spicy foods and culturally rooted beliefs in “food as medicine” observed in certain regions³⁵. Therefore, we recommend integrating sterile dietary principles with local food cultures to develop modified recipes for HSCT patients.

Complication events may serve as valuable catalysts for enhancing self-management efficacy among HSCT patients. First, when complications arise, patients require adequate support to cope effectively, including family support, peer educational guidance, and medical care as identified herein. Second, complications should be regarded not only as clinical challenges but also as key opportunities for reinforcing health education and facilitating behavioral adaptation. Such events can re-engage patients’ risk awareness and strengthen self-efficacy, thereby promoting more sustainable self-management behaviors. To support this process, wearable devices and mobile health platforms can be leveraged to provide real-time feedback on physiological parameters, allowing patients to make timely and adaptive modifications to their self-management routines⁴³. However, differ in their clinical trajectories and psychological responses, which may result in fluctuating levels of risk perception and self-efficacy. Therefore, interventions should be integrated with dynamic assessment to support patients in maintaining optimal levels of risk perception and self-management efficacy throughout the recovery process^44,45.

Study limitations

First, the sample was drawn from a single hospital in south-central China, which may limit the generalizability and representativeness of the findings. Regional variations in healthcare policies and access to services may influence self-management behaviors, and as a result, the experiences of patients in other regions may differ. Second, recall bias is a potential limitation, particularly among patients with a longer post-transplant recovery period, who may find it difficult to accurately recall their symptom experiences and self-management behaviors. Third, the relatively short duration of this study may not provide a comprehensive view of how patients’ self-management evolves over time or the challenges they may encounter.

Conclusion

The qualitative study applied the HAPA framework to explore the risk perception, self-management challenges, and coping strategies among HSCT patients. The findings indicate that high risk perception and self-efficacy promote engagement in self-management during the peri-transplant period. However, the volitional phase presents challenges, including symptom management and psychological distress. To support clinical practice, healthcare providers can harness patients’ elevated risk perception and self-efficacy during the peri-transplant period to encourage the adoption of effective self-management behaviors. To address the decline in risk perception and self-efficacy in the early post-discharge phase, tailored interventions and resources should be provided to sustain patients’ motivation and ability to maintain self-management practices.

Footnotes

Acknowledgements

We thank all the HSCT patients for participating and sharing their experiences.

ORCID iD

Xiaoyan Yu

Ethical Considerations

The study was approved by the ethics committee of The Second Xiangya Hospital of Central South University (No. 2024-0275) and was conducted in accordance with the Declaration of Helsinki.

Consent to Participate

Written informed consent was obtained from each participant.

Author Contributions

X.Y. drafted the manuscript. H.Y. and X.Y. contributed to the conception and design of the study. H.Y., Z.X., and X.L. contributed to data acquisition, analysis, and interpretation. H.Y. provided research supervision. X.Y. critically revised the manuscript. All authors have full access to all study data and are responsible for ensuring data integrity and accuracy of the analysis.

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Natural Science Foundation of Hunan Province (Grant No. 2024JJ9227), Joint Funding Project of Hunan Provincial Natural Science Foundation and Hunan Xiangya Boai Rehabilitation Hospital Co Ltd. (Grant No. 2025JJ90296) and Science Popularization Foundation of Hunan Province (Grant No. 2023ZK4105).

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Data Availability Statement

All data generated or analyzed during this study are included in this published article.

Statement of Human and Animal Rights

This article does not contain any studies with human or animal subjects.

Statement of Informed Consent

There are no human subjects in this article and informed consent is not applicable.

Clinical Trial Number

Not applicable.

References

Mushtaq

Shahzad

Tariq

Iqbal

Chaudhary

Zafar

Anwar

Ahmed

Bansal

Singh

Abhyankar

, et al. Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: a systematic review and meta-analysis. Front Oncol. 2022;12:1005042.

Huang

Jiang

Liu

Cao

Zhang

NN.

Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group. Bone Marrow Transplant. 2025;60(2).

Duarte

Labopin

Bader

Basak

Bonini

Chabannon

Corbacioglu

Dreger

Dufour

Gennery

Kuball

, et al. European Society for Blood and Marrow Transplantation (EBMT). Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant. 2019;54(10):1525–52.

Greinix

Eikema

Koster

Penack

Yakoub-Agha

Montoto

Chabannon

Styczynski

Nagler

Robin

Robinson

, et al. Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study. Haematologica. 2022;107(5):1054–63.

Abraham

Mishra

Bhatnagar

Kumar

Sharma

Garg

Bharati

Gupta

Kumar

Quality of life and symptom burden in hematological cancer patients receiving hematopoietic stem cell transplantation: an observational study at Regional Cancer Centre, India. Support Care Cancer. 2024;32(5):274.

Ruan

Cheng

Liu

Kwok

WYY

Luo

Qian

Cheung

DST

Yeung

WF.

Survivorship experiences of allogeneic hematopoietic stem cell transplantation survivors: a qualitative systematic review. Cancer. 2024;11:1–8.

Penack

Marchetti

Aljurf

Arat

Bonifazi

Duarte

Giebel

Greinix

Hazenberg

Kröger

Mielke

, et al. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2024;11(2):e147–59.

Chang

Pei

Huang

XJ.

Hematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions. Lancet Haematol. 2022;9(12):e919–e929.

Barlow

Wright

Sheasby

Turner

Hainsworth

Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48(2):177–87.

10.

Chen

Xie

Understanding the symptom experience and self-management strategies of adult hematopoietic stem cell transplantation patients during hospitalization: findings from a qualitative longitudinal study. Support Care Cancer. 2022;30(12):10137–47.

11.

Yanling

Duorong

Zhiyong

Ting

Wenjun

Xiangzhong

Jingwen

Psychological states and needs among post-allogeneic hematopoietic stem cell transplantation survivors. Cancer Med. 2023;12(15):16637–48.

12.

Nascimento

AAA

Melo

JCA

Soares

Marinho

ACL

Ribeiro

SEA

Azevedo

. Self-care guidelines for patients in the post-hematopoietic stem cell transplantation period: a scoping review. Rev Bras Enferm. 2023;76(4):e20220383.

13.

Amato

Iovino

Longobucco

Salvadori

Diaz

Castiglione

Guadagno

Vellone

Rasero

Reciprocal associations between beliefs about medicines, health locus of control and adherence to immunosuppressive medication in allogeneic hematopoietic cell transplant patients: findings from the ADE-TRAM study. Eur J Oncol Nurs. 2023;67:102410.

14.

Kim

McErlean

Kerridge

Greenwood

Lourenco

RA.

Healthcare resource utilization and cost associated with allogeneic hematopoietic stem cell transplantation: a scoping review. Transplant Cell Ther. 2024;30(5):542.e1–542.e29.

15.

Khera

Turnbull

Stewart

Williams

Bhatt

Meyers

Galvin

Lee

SJ.

Impact of chronic graft-versus-host disease on patient employment, income, and informal caregiver burden: findings from the living with chronic GVHD patient survey. Transplant Cell Ther. 2023;29(7):470.e1–470.e9.

16.

Posluszny

Bovbjerg

Syrjala

Agha

Farah

Hou

Raptis

Dorritie

Boyiadzis

Dew

MA.

Rates and predictors of nonadherence to the post-allogeneic hematopoietic cell transplantation medical regimen in patients and caregivers. Transplant Cell Ther. 2022;28(3):165.e1–165.e9.

17.

McCune

Armenian

Nakamura

Shan

Kanakry

Mielcarek

Gao

Mager

DE.

Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients. J Oncol Pharm Pract. 2024;30(2):322–31.

18.

Diaz

Schneller

Fix

Bansal-Travers

Colder

O’Connor

. Exploring the psychometric properties of a tripartite model of risk perception (TRIRISK) in a general U.S. Health Psychol Behav Med. 2022;10(1):1110–23.

19.

Feng

Yingli

Qian

Correlation study between risk perception and self—management level in middle—aged and young type 2 diabetes mellitus patients. J Nursing Research. 2023;37(4):590–95.

20.

Riedinger

Campbell

Klein

WMP

Ferrer

Usher-Smith

JA.

Analysis of the components of cancer risk perception and links with intention and behaviour: a UK-based study. PLoS ONE. 2022;17(1):e0262197.

21.

Watson

A postmodernist qualitative research approach: choosing between descriptive and interpretive phenomenology. J Adv Nursing. 2024;81:6968–73.

22.

Schwarzer

Lippke

Luszczynska

Mechanisms of health behavior change in persons with chronic illness or disability: the Health Action Process Approach (HAPA). Rehabil Psychol. 2011;56(3):161–70.

23.

Guo

Sun

Chen

Gao

Chen

Analysis of the current situation of exercise behavior of patients with type 2 diabetes mellitus based on the theoretical model of health action process orientation. Chin J Dis Control Prev. 2022;26(1):56–6098.

24.

Kiger

Varpio

Thematic analysis of qualitative data: AMEE guide no. Med Teach. 2020;42(8):846–54.

25.

Braun

Clarke

Is thematic analysis used well in health psychology? A critical review of published research, with recommendations for quality practice and reporting. Health Psychol Rev. 2023;17(4):695–718.

26.

Thompson Burdine

Thorne

Sandhu

. Interpretive description: a flexible qualitative methodology for medical education research. Med Educ. 2021;55(3):336–43.

27.

Buus

Perron

The quality of quality criteria: replicating the development of the Consolidated Criteria for Reporting Qualitative Research (COREQ). Int J Nurs Stud. 2020;102:103452.

28.

Malterud

Siersma

Guassora

AD.

Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26(13):1753–60.

29.

Malterud

Systematic text condensation: a strategy for qualitative analysis. Scand J Public Health. 2012;40(8):795–805.

30.

Malik

Amir

Kusumawardhani

AAAA

Lukman

Karnovinanda

Melisa

Dewi

Lasmono

Health Action Process Approach (HAPA) as a framework to understand compliance issues with health protocols among people undergoing isolation at emergency hospital for COVID-19 Wisma Atlet Kemayoran and RSCM Kiara Ultimate Jakarta Indonesia. Front Psychiatry. 2022;13:871448.

31.

Zhou

Sun

Study on medication adherence in patients with gestational diabetes mellitus complicated by postpartum glucose metabolism disorders based on the risk perception attitude framework. Front Endocrinol. 2025;16:1501541.

32.

Ranjbaran

Shojaeizadeh

Dehdari

Yaseri

Shakibazadeh

Determinants of medication adherence among Iranian patients with type 2 diabetes: an application of health action process approach. Heliyon. 2020;6(7):e04442.

33.

Lin

Zhang

Guo

Wang

Mei

Wang

Tong

Shuaib

Cheung

Perceptions of recurrence risk and behavioral changes among first-ever and recurrent stroke survivors: a qualitative analysis. Health Expect. 2021;24(6):1962–70.

34.

Inoue

Saito

Makiura

Ono

Doi

Yakushijin

Sakai

. Factors influencing life space mobility in cancer survivors following hematopoietic stem cell transplantation-physical function, depression, fatigue, neighborhood walkability, and employment status. Hematol Oncol Stem Cell Ther. 2024;17(2):146–53.

35.

Chen

Wang

Wen

Symptom experience and self-management strategies of adults undergoing hematopoietic stem cell transplantation after hospital discharge: a longitudinal qualitative study. Eur J Oncol Nurs. 2024;72:102666.

36.

Wang

Dong

Tan

Lin

Zhou

Recurrence risk perception, fear of progression, and health behaviors among patients with ischemic stroke. West J Nurs Res. 2024;46(10):799–810.

37.

Visintini

Lucchetta

Venturini

Mansutti

Chiappinotto

Patriarca

Palese

Perspective on oral medication adherence among patients with acute graft-versus-host disease: a qualitative descriptive study. Support Care Cancer. 2024;32(10):633.

38.

Liu

Wang

Shan

Wang

Luo

Zou

Yang

Wang

Zhang

, et al. Shared decision-making about autologous stem cell transplantation: a qualitative study of older patients and physicians. J Am Geriatr Soc. 2024;11:1–8.

39.

Kaundinya

El- Behaedi

Choi

JN.

Content analysis and dermatologic gaps in online patient education materials for graft-versus-host disease. Arch Dermatol Res. 2023;315(4):1063–66.

40.

Farhadfar

Weaver

Al-Mansour

Jim

HSL

Loren

Majhail

Whalen

Uberti

Wingard

Lynch Kelly

, et al. Self-efficacy for symptom management in long-term adult hematopoietic stem cell survivors. Transplant Cell Ther. 2022;28(9):606.e1–606.e8.

41.

Keane

Guo

Gudenkauf

Boardman

Song

Wolfe

Larizza

Mate-Kole

Healy

Huffman

El-Jawahri

, et al. A peer support intervention in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT): the STEPP randomized pilot trial design and methods. Contemp Clin Trials. 2025;148:107746.

42.

Amonoo

Deary

Wang

Newcomb

Daskalakis

Weber

Holmbeck

Choe

Nabily

Cutler

Traeger

, et al. Medication adherence in patients with hematologic malignancies who are hematopoietic stem cell transplantation survivors: a qualitative study. Transplant Cell Ther. 2023;29(10):620.e1–620.e11.

43.

Visintini

Mansutti

Palese

Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a systematic review protocol. BMJ Open. 2022;12(12):e065676.

44.

Parisek

Loss

Holler

Barata

Weber

Edinger

Wolff

Schoemans

Herrmann

“This graft-vs.-host disease determines my life. That’s it.” A qualitative analysis of the experiences and needs of allogenic hematopoietic stem cells transplantation survivors in Germany. Front Public Health. 2021;9:687675.

45.

Dovern

Nijland

SJAM

van Muilekom

Suijk

LMJ

Hoogendoorn

Mekelenkamp

Biemond

Haverman

Nur

Physical, mental, and social health of adult patients with sickle cell disease after allogeneic hematopoietic stem cell transplantation: a mixed-methods study. Transplant Cell Ther. 2023;29(4):283.e1–283.e9.